Caliper Life Sciences is a leading provider of cutting-edge technologies enabling researchers in the life sciences to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper has compiled numerous best-in-class solutions and is aggressively innovating new technologies to bridge the gaps that exist in bringing in vitro assays to in vivo results and ultimately into cures for human disease.
Agilent Life Sciences and Chemical Analysis is a leading global provider of instrumentation, supplies, software and services to the life science and chemical analysis markets.
Agilent provides the worlds most complete, most reliable laboratory productivity solutions, optimized for your applications and workflows. Agilent's complete menu of services includes instrument maintenance and repair, compliance support, software integration, consulting and educationall designed to protect your investment and assure the highest possible levels of uptime.
AcryMed is a pioneering innovator at the forefront of discoveries in the fields of infection control and wound healing. The company’s SilvaSorb® products for advanced wound care and SilvaGard® antimicrobial surface treatment for medical devices are among the breakthrough technologies that have distinguished AcryMed as an industry leader.
AcryMed's latest product line is OxygeneSys™ Dissolved Oxygen Dressings.
We were the first to identify the combination of microfluidics and light responsive polymers being developed by Molecular Vision in London as having the potential of completely revolutionising the Point of Care (PoC) diagnostics market. This lab on a chip diagnostic platform has the potential to produce simple to use compact, low cost, hand held device where the analytical capabilities of a number of standard pieces of laboratory equipment can be duplicated.
Abraxis Oncology® is the proprietary pharmaceuticals division of Abraxis BioScience, LLC, an integrated global bio-pharmaceutical company. Abraxis Oncology® is dedicated to the discovery and development of novel cancer therapies that target tumor biological pathways. Our focus is to challenge current standards and develop next-generation therapies that revolutionize the treatment of cancer.
Ablynx is focused on the discovery and development of Nanobodies®, a novel class of antibody-derived therapeutic proteins based on single-domain antibody fragments, for a range of serious life-threatening human diseases. Ablynx is developing a portfolio of Nanobody®-based therapeutic programmes in a number of major disease areas, including inflammation, thrombosis, oncology and Alzheimer's disease. The unique structure and stability of Nanobodies® has allowed Ablynx, and its partners, to pursue targets that are typically difficult to reach with conventional antibodies.
eSpin Technologies, Inc. is a high-tech manufacturing company. The company provides global leadership in polymeric nanofiber manufacturing technology applicable across the universe of emergent and traditional manufacturing sectors. eSpin's nanofibers are 20-200nm in diameter, have a very high surface area to mass ratio, and can be formed into membranes with very high porosity.
Liquidia Technologies is developing engineered particle-based vaccines and therapeutics that have the potential to dramatically improve the quality of human life. Utilizing a novel technology known as the PRINT® platform, Liquidia is creating rationally-design carriers for improved delivery of small molecule and biological cargos.